4/1
09:04 am
axsm
Axsome Therapeutics, Inc. (NASDAQ: AXSM) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $153.00 price target on the stock.
Low
Report
Axsome Therapeutics, Inc. (NASDAQ: AXSM) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $153.00 price target on the stock.
4/1
08:53 am
axsm
Rating for AXSM
Low
Report
Rating for AXSM
4/1
08:53 am
axsm
Rating for AXSM
Low
Report
Rating for AXSM
3/27
08:35 am
axsm
Rating for AXSM
Low
Report
Rating for AXSM
3/27
08:35 am
axsm
Rating for AXSM
Low
Report
Rating for AXSM
3/6
08:12 am
axsm
Axsome Therapeutics, Inc. (NASDAQ: AXSM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $200.00 price target on the stock.
Low
Report
Axsome Therapeutics, Inc. (NASDAQ: AXSM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $200.00 price target on the stock.
3/3
12:41 pm
axsm
Axsome Therapeutics, Inc. (NASDAQ: AXSM) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $153.00 price target on the stock.
Low
Report
Axsome Therapeutics, Inc. (NASDAQ: AXSM) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $153.00 price target on the stock.
3/3
12:28 pm
axsm
Rating for AXSM
Low
Report
Rating for AXSM
3/3
12:28 pm
axsm
Rating for AXSM
Low
Report
Rating for AXSM
3/3
07:43 am
axsm
Rating for AXSM
Low
Report
Rating for AXSM
3/3
07:43 am
axsm
Rating for AXSM
Low
Report
Rating for AXSM
2/27
08:13 am
axsm
Rating for AXSM
Medium
Report
Rating for AXSM
2/27
08:13 am
axsm
Rating for AXSM
Medium
Report
Rating for AXSM
2/26
11:08 am
axsm
Rating for AXSM
Low
Report
Rating for AXSM
2/26
11:08 am
axsm
Rating for AXSM
Low
Report
Rating for AXSM
2/24
08:48 am
axsm
Rating for AXSM
Medium
Report
Rating for AXSM
2/24
08:48 am
axsm
Rating for AXSM
Medium
Report
Rating for AXSM
2/19
10:33 am
axsm
Axsome Therapeutics, Inc. (NASDAQ: AXSM) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $153.00 price target on the stock.
Low
Report
Axsome Therapeutics, Inc. (NASDAQ: AXSM) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $153.00 price target on the stock.
2/19
10:29 am
axsm
Rating for AXSM
Low
Report
Rating for AXSM
2/19
10:29 am
axsm
Rating for AXSM
Low
Report
Rating for AXSM
2/19
10:24 am
axsm
Rating for AXSM
Low
Report
Rating for AXSM
2/19
07:20 am
axsm
Rating for AXSM
Low
Report
Rating for AXSM
2/19
07:20 am
axsm
Rating for AXSM
Low
Report
Rating for AXSM
2/18
10:11 am
axsm
Axsome Therapeutics, Inc. (NASDAQ: AXSM) had its "outperform" rating re-affirmed by analysts at William Blair.
Low
Report
Axsome Therapeutics, Inc. (NASDAQ: AXSM) had its "outperform" rating re-affirmed by analysts at William Blair.
2/18
10:11 am
axsm
Axsome Therapeutics, Inc. (NASDAQ: AXSM) had its "outperform" rating re-affirmed by analysts at William Blair.
Low
Report
Axsome Therapeutics, Inc. (NASDAQ: AXSM) had its "outperform" rating re-affirmed by analysts at William Blair.